POCKIT™ Central COVID-19 Assay
Infectious Disease
commercialActive
Key Facts
About GeneReach Biotechnology
Taiwanese point‑of‑care molecular diagnostics company leveraging insulated isothermal PCR technology.
View full company profileOther Infectious Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Vaccine Platform | Biolingus | Research |
| Pipeline Antibiotics | BioQ Pharma | Unknown |
| Antivirals Platform | Qubit Pharmaceuticals | Discovery |
| Antibiotic Development Program | AF ChemPharm | Pre-clinical |
| Prophylactic Vaccine Development | ImmuneSpec | Service |
| Optimized VHH vs. SARS-CoV-2 | Ordaos Bio | Pre-clinical |
| AmorphOX Vaccine | Orexo | Preclinical |
| Undisclosed Vaccine Program(s) | Brazos Biomedical | Pre-clinical |
| Undisclosed Asset 1 | Uvax Bio | Research |
| Undisclosed Asset 2 | Uvax Bio | Research |
| Undisclosed Asset 3 | Uvax Bio | Research |
| Vaccine Immune Response (SARS-CoV-2) | CellChorus | Preclinical |